Omeprazole plus antibiotics in the eradication of Helicobacter pylori infection: A meta-regression analysis of randomized, controlled trials

American Journal of Therapeutics

Volumn 6, Issue 1, 1999, Pages 25-36

  Schmid, Christopher H ^a,b   Whiting, Gregory ^c   Cory, Douglas ^a   Ross, Susan D ^c   Chalmers, Thomas C ^a,b,c  

^a TUFTS MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MetaWorks Inc   (United States)

Author keywords

Eradication; Helicobacter pylori; Meta analysis; Treatment

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CLARITHROMYCIN; IMIDAZOLE DERIVATIVE; OMEPRAZOLE;

ANTIBIOTIC THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; GASTRITIS; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; META ANALYSIS; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REGRESSION ANALYSIS; TREATMENT OUTCOME;

EID: 0032914456     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-199901000-00005     Document Type: Article

References (18)

1. Davies GR, Crabtree JE: Helicobacter pylori: Trick or treat? J R Soc Med 1994;87:436-439.
2. Rauws E, Tytgat GNJ: Eradication of Helicobacter pylori cures duodenal ulcer. Lancet 1990;1:1233.
3. NIH Consensus Conference: Helicobacter pylori in peptic ulcer disease. JAMA 1994;172:65-69.
4. Hunt RH: Eradication of Helicobacter pylori infection. Am J Med 1996;100(Suppl 5A):42S-51S.
5. Soll AH: Medical treatment of peptic ulcer disease. Practice Guidelines. JAMA 1996:275:622-629.
6. Van der Hulst RWM, Keller JJ, Rauws EAJ, et al: Treatment of Helicobacter pylori infection: A review of the world literature. Helicobacter 1996;1:6-19.
7. Treiber G: The influence of drug dosage on Helicobacter pylori eradication: A cost-effectiveness analysis. Am J Gastroenterol 1996;91:246-257.
8. Mulrow CD: The medical review article: State of the science. Ann Intern Med 1987;104:485-488.
9. Oxman AD, Guyatt GH: Guidelines for reading literature reviews. Can Med Assoc J 1988;138:697-703.
10. Chalmers TC, Celano P, Sacks HS, et al: Bais in treatment assignment in controlled clinical trials. N Engl J Med 1983;309;1358-1361.
11. Chalmers TC, Ross SD, Neil G, et al: A year after the NIH Consensus Statement on eradication of H. pylori in peptic ulcer disease: How best to do it? Digestive Disease Week, May 14-17, 1995: A-50 (#198).
12. Labenz J, Leverkus F, Borsch G: Omeprazole plus amoxicillin for cure of Helicobacter pylori infection: Factors influencing the treatment success. Scand J Gastroenterol 1994;29:1070-1075.
13. Barthel JS, Everett ED: Diagnosis of Campylobacter pylori infections: The "gold standard" and the alternatives. Rev Infect Dis 1990:12(Suppl):S107-S114.
14. Mainguet P, Delmee M, Debongnie JC: Omeprazole, Campylobacter pylori, and duodenal ulcer disease. Lancet 1989;2:389-390.
15. Graham DY, Lew GM, Malaty HM, et al: Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992;102:493-496.
16. Miehlke S, Bayerdorffer E, Lehn N, et al: Helicobacter pylori reinfection in duodenal and gastric ulcer patients after antibacterial treatment. Gastroenterology 1995;108 (Part 4 Suppl):A167.
17. Talley NJ: A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia. Gastroenterology 1994;106:1174-1183.
18. Borzak S, Ridker PM: Discordance between meta-analysis and large scale randomized controlled trials. Ann Intern Med 1995;123:873-877.